EGFR-TKI plus anti-angiogenic drugs in EGFR-mutated NSCLC:...

  • Main
  • 2020 / 07
  • EGFR-TKI plus anti-angiogenic drugs in EGFR-mutated NSCLC:...
JNCI Cancer Spectrum 2020 / 07

EGFR-TKI plus anti-angiogenic drugs in EGFR-mutated NSCLC: a meta-analysis of randomized clinical trials

Conforti, Fabio, Pala, Laura, Bagnardi, Vincenzo, Specchia, Claudia, Oriecuia, Chiara, Marra, Antonio, Zagami, Paola, Morganti, Stefania, Tarantino, Paolo, Catania, Chiara, De Marinis, Filippo, Queiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
JNCI Cancer Spectrum
DOI:
10.1093/jncics/pkaa064
Date:
July, 2020
File:
PDF, 2.06 MB
2020
Conversion to is in progress
Conversion to is failed